Comments
Loading...

NeuroSense Therapeutics

NRSNNASDAQ
$0.784800
-0.09-10.67%
Last update: 3:17 PM
15 minutes delayed

NeuroSense Therapeutics (NASDAQ:NRSN) Stock, Earnings Estimates, EPS, And Revenue

NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 14
EPS Estimate
$-0.200
Quarterly Revenue Estimate
Annual Revenue
(as of Mar 31)

Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.

Get Alert
NRSN
NeuroSense Therapeutics
-$0.44-$0.20$0.0008/14/2024Get Alert
NRSN
NeuroSense Therapeutics
-$0.33-$0.20-$0.35-75.00%$0.00$0.0006/24/2024Get Alert
NRSN
NeuroSense Therapeutics
-$0.27-$0.23-$0.1630.43%$0.00$0.0004/05/2024Get Alert
NRSN
NeuroSense Therapeutics
-$0.25$0.10$0.00$0.0011/28/2023Get Alert
NRSN
NeuroSense Therapeutics
-$0.31-$0.44$0.00$0.0008/16/2023Get Alert
NRSN
NeuroSense Therapeutics
-$0.24-$0.33$0.00$0.0006/01/2023Get Alert
NRSN
NeuroSense Therapeutics
-$0.27$0.0003/22/2023Get Alert
NRSN
NeuroSense Therapeutics
$0.93-$0.25$0.00$0.0012/01/2022Get Alert
NRSN
NeuroSense Therapeutics
-$1.24-$0.31$0.00$0.0008/31/2022Get Alert
NRSN
NeuroSense Therapeutics
-$0.38-$0.24$0.00$0.0005/31/2022Get Alert

NeuroSense Therapeutics (NRSN) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-06-24$-0.35$-0.20-75.0 %
Mar 20242024-04-05$-0.16$-0.2330.4 %

NeuroSense Therapeutics (NRSN) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?

A

NeuroSense Therapeutics (NRSN) is scheduled to report earnings on August 14, 2024. The last reported earnings were for reported on June 24, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for NeuroSense Therapeutics (NASDAQ:NRSN)?

A

The Actual EPS was $-0.35, which missed the estimate of $-0.20.

Q

What were NeuroSense Therapeutics’s (NASDAQ:NRSN) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.